The official version of this document can be found via the PDF button.
The below content has been automatically generated from the original PDF and some formatting may have been lost, therefore it should not be relied upon to extract citations or propose amendments.
5
WQ.203/2018
WRITTEN QUESTION TO THE MINISTER FOR HOME AFFAIRS BY DEPUTY M. TADIER OF ST. BRELADE
ANSWER TO BE TABLED ON TUESDAY 23rd OCTOBER 2018
Question
Will the Minister state what content of tetrahydrocannabinol (T.H.C.) is legally allowed in so-called C.B.D. oil'(Cannabidiol) which is sold over the counter as a health supplement in Jersey; and advise what testing, if any, is done to ascertain that such imported products do not contain levels of T.H.C. that exceed the legal limit?
Answer
At present, the Misuse of Drugs (Jersey) Law 1978 controls cannabinol derivatives under Class A drugs.
Cannabinol derivatives are defined under Part 4 of the Law as the following substances, except where contained in cannabis or cannabis resin, namely tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives.' Tetrahydrocannabinol (T.H.C.) falls under this definition and therefore THC as a pure compound is a Class A drug.
It should be noted that cannabidiol (CBD) as a pure substance is not caught by any of these definitions and is therefore not controlled under the law.
The presence of any THC in a product would make that product a controlled substance under the law. Some controlled substances do have thresholds below which they are not considered controlled but there is no threshold for cannabinol derivatives.
It is for the importer of a product to demonstrate the content of THC in that product. This could be done via the provision of a Certificate of Analysis from a recognised laboratory confirming the THC content.